We attended UBS’s annual Global Healthcare Conference 2016 from May 23th to 25th in New York.
The last 10 months – since the market peak in August 2015 – have been rough for healthcare investors and executives of healthcare companies alike. Executives presenting at the UBS conference seemed relieved and encouraged by the more constructive market environment lately.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.